Objective: The COVID 19 pandemic has been the biggest health problem in the last 2 years, exerting huge pressure on the global healthcare system. Studies showed a predisposition in men to develop more severe forms, with a higher mortality rate, in comparison to women. Also, men infected with SARS CoV2 would be at higher risk of hospitalization in acute intensive care units (ICU) with complications that could lead to death Methods: We conducted a retrospective cross-sectional study that included 177 hospitalized patients in a time frame of 18 months with SARS CoV2 infection confirmed by RT PCR testing in the Pneumology Department of the Clinical Hospital of Pneumophtisiology of Constanta, Romania. The information needed to conduct the study was gathered from the patient’s general clinical observation sheet and included: the smoker/ non-smoker status of the patient, age, symptoms associated with COVID19 infection, biological data, form of disease, treatment administered during hospitalization. Results: The study group included 177 patients, 42% of whom were women (82) and 54% were men (95), suggesting a higher incidence of SARS CoV2 infection in males. The most dominant symptom was cough in 62% cases of women and 56% cases of men. Females had a higher incidence of anosmia (11%) and ageusia (2%) compared to males (anosmia, ageuzia-1%). A higher predominance of women developing moderate forms compared to males. Severe forms were found in 22% of cases in women and 23% in men. Conclusions: It is inconclusive if male patients show a more severe evolution of COVID19 infection compared to females. Women have shown a predisposition to symptoms such as ageusia, anosmia and a more severe inflammatory syndrome

Aim: The issue of body weight has left a deep mark on the COVID-19 pandemic, where this category of patients has been linked to significant increases in morbidity and mortality due to infection. Conversely, due to the restrictions imposed, the pandemic has worsened the situation of overweight people. Our study conducted over a period of one year and five months aims to assess the prevalence of obesity among patients with SARS-COV2 infection in Constanta County. Material and method: This retrospective study included a number of 177 patients hospitalized with the diagnosis of SARS-COV2 infection in the Clinical Hospital of Pneumoftiziology Constanta. Results: 2483 of patients confirmed with SARS-COV2 infection were identified in our Department, out of which 302 had a body mass index over 30 kg/m2. We included a random sample of 95 men and 82 women in a database. The average age was 55 years. The most common comorbidities were hypertension (48%), diabetes (13%), and cardiovascular disease (12%). The most common symptoms were fever (67%), cough (58%), dyspnea (37%), and asthenia (29%). The radiological appearance showed the predominance of the moderate form (49%) and the severe form (22%). Antibiotic treatment was based on third-generation cephalosporins (53%), and the evolution was for improvement with a survival rate of 86%. Only one death was reported in our study. Conclusion: The body mass index influences the evolution of infected cases. Old age, male gender and associated comorbidities are risk factors for a poorer prognosis and greater complications in patients with SARS-COV2.

The World Health Organization (WHO) declares COVID 19 pandemic in March 2020. Each pandemic wave had different clinical and biological characteristics, the expression of the disease being correlated with the dominant viral variant. Patients with COVID 19 have a pro-coagulant status, which predisposes them to thromboembolic complications. The current study aims to systematize the symptoms of COVID 19 and to highlight its relationship with the suspicion and confirmation of the diagnosis of pulmonary thromboembolism. We performed a descriptive retrospective study on patients with COVID 19 for a period of 4 months (September-December 2021). During this period, 183 were hospitalized with COVID 19 and 53 were enrolled in the study. Incidence of COVID 19 was 63% (33) in men and 37% for women. The average age of women was 68 years compared to men where the average age was 61 years. We observed a higher incidence of the disease in men in the 41–60 age group (39% of all men), while, in women, the most affected age group was 61–80 years (60% of all women). Pulmonary thromboembolism (PE) was diagnosed by pulmonary artery angiography, with an incidence of 57% in the study group affecting 60% of women and 55% of men. The symptoms are dominated by fever, cough and dyspnea. Fever was present in 65% of women and 55% of men, cough was present in 65% of women and 79% of men, while dyspnea involved 40% of women and 42% of men. In conclusion, PE was a common complication in COVID patients that contributed to adverse outcome and higher mortality. The symptoms were not specific to minor forms of the disease.